These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8772828)

  • 21. Circulating CD34+ cell counts are predictive of CD34+ peripheral blood progenitor cell yields.
    Bandarenko N; Sims LC; Brecher ME
    Transfusion; 1997; 37(11-12):1218; author reply 1218-20. PubMed ID: 9426651
    [No Abstract]   [Full Text] [Related]  

  • 22. Optimal CD34(+) cell dose in autologous peripheral-blood stem-cell transplantation.
    Sezer O; Possinger K; Metzner B; Illiger HJ; Wattad M; Heit W; Fuss H; Schultze W
    J Clin Oncol; 2000 Sep; 18(18):3319-20. PubMed ID: 10986066
    [No Abstract]   [Full Text] [Related]  

  • 23. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
    Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
    Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD34 epitope expression on haemopoietic tissues.
    Titley I; Healy LE; Gordon MY
    Br J Haematol; 1997 Sep; 98(3):779-80. PubMed ID: 9332341
    [No Abstract]   [Full Text] [Related]  

  • 25. Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood.
    Huang GP; Pan ZJ; Jia BB; Zheng Q; Xie CG; Gu JH; McNiece IK; Wang JF
    Cell Transplant; 2007; 16(6):579-85. PubMed ID: 17912949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematopoietic stem and progenitor cells.
    Donahue RE; Chen IS
    Methods Mol Biol; 2003; 229():117-30. PubMed ID: 12824626
    [No Abstract]   [Full Text] [Related]  

  • 27. Absence of a CD34- hematopoietic precursor population in recipients of CD34+ stem cell transplantation.
    Kato S; Ando K; Nakamura Y; Muguruma Y; Sato T; Yabe H; Yabe M; Hattori K; Yasuda Y; Hotta T
    Bone Marrow Transplant; 2001 Sep; 28(6):587-95. PubMed ID: 11607772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enumeration of CD34+ hematopoietic precursor cells: current status.
    Reis MD
    Transplant Proc; 1999 Nov; 31(7):2970-2. PubMed ID: 10578353
    [No Abstract]   [Full Text] [Related]  

  • 29. Human umbilical cord blood: immunophenotypic heterogeneity of CD34+ hematopoietic progenitor cells.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Zendoli F; Carotenuto M
    Haematologica; 1996; 81(5):404-9. PubMed ID: 8952152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. More on the appropriate fluorochrome-conjugated CD34 antibody choice for the flow cytometric detection of circulating progenitor cells.
    D'Arena G; Carotenuto M
    Haematologica; 1998 Jan; 83(1):93-4. PubMed ID: 9542330
    [No Abstract]   [Full Text] [Related]  

  • 31. Imprecision of counting CFU-GM colonies and CD34-expressing cells.
    Serke S; Arseniev L; Watts M; Fritsch G; Ingles-Esteve J; Johnsen HE; Linch D; Cancelas JA; Meyer O; Kadar JG; Huhn D; Matcham J
    Bone Marrow Transplant; 1997 Jul; 20(1):57-61. PubMed ID: 9232258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and characterization of canine hematopoietic progenitor cells.
    Niemeyer GP; Hudson J; Bridgman R; Spano J; Nash RA; Lothrop CD
    Exp Hematol; 2001 Jun; 29(6):686-93. PubMed ID: 11378263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progenitor cell subsets and engraftment kinetics in children undergoing autologous peripheral blood stem cell transplantation.
    Gonzalez-Requejo A; Madero L; Díaz MA; Villa M; García-Escribano C; Balas A; Lillo R; García-Sanchez F; Benito A; Vicario JL
    Br J Haematol; 1998 Apr; 101(1):104-10. PubMed ID: 9576190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics and immunophenotypic characterization of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation.
    Albo C; de la Fuente J; Ares C; Alonso C; Feteira E
    Haematologica; 2004 Jul; 89(7):845-51. PubMed ID: 15257937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of CD133 on a human cell line lacking CD34.
    Delfini C; Centis F; Falzetti F; Tabilio A
    Leukemia; 2002 Oct; 16(10):2174-5; author reply 2175. PubMed ID: 12357381
    [No Abstract]   [Full Text] [Related]  

  • 36. Human CD34- hematopoietic stem cells: basic features and clinical relevance.
    Ando K
    Int J Hematol; 2002 May; 75(4):370-5. PubMed ID: 12041666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-color immune-phenotyping of CD34 subsets reveals unexpected differences between various stem cell sources.
    Dmytrus J; Matthes-Martin S; Pichler H; Worel N; Geyeregger R; Frank N; Frech C; Fritsch G
    Bone Marrow Transplant; 2016 Aug; 51(8):1093-100. PubMed ID: 27042837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CD34+Thy1+ cell population: are they all stem cells?
    McNiece I
    Exp Hematol; 2000 Dec; 28(12):1312-4. PubMed ID: 11188921
    [No Abstract]   [Full Text] [Related]  

  • 39. Hematopoietic stem cells: are they CD34-positive or CD34-negative?
    Nakauchi H
    Nat Med; 1998 Sep; 4(9):1009-10. PubMed ID: 9734390
    [No Abstract]   [Full Text] [Related]  

  • 40. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
    Choi D; Perrin M; Hoffmann S; Chang AE; Ratanatharathorn V; Uberti J; McDonagh KT; Mulé JJ
    Clin Cancer Res; 1998 Nov; 4(11):2709-16. PubMed ID: 9829733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.